Rhinomed Limited RNO.AX Stock
Rhinomed Limited Price Chart
Rhinomed Limited RNO.AX Financial and Trading Overview
| Rhinomed Limited stock price | 0.04 AUD |
| Previous Close | 0.07 AUD |
| Open | 0.07 AUD |
| Bid | 0.07 AUD x 0 |
| Ask | 0.08 AUD x 0 |
| Day's Range | 0.07 - 0.07 AUD |
| 52 Week Range | 0.07 - 0.19 AUD |
| Volume | 4.95K AUD |
| Avg. Volume | 97.76K AUD |
| Market Cap | 20M AUD |
| Beta (5Y Monthly) | 0.76475 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RNO.AX Valuation Measures
| Enterprise Value | 21.11M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.1256666 |
| Price/Book (mrq) | 70 |
| Enterprise Value/Revenue | 2.244 |
| Enterprise Value/EBITDA | -3.181 |
Trading Information
Rhinomed Limited Stock Price History
| Beta (5Y Monthly) | 0.76475 |
| 52-Week Change | -48.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 AUD |
| 52 Week Low | 0.07 AUD |
| 50-Day Moving Average | 0.08 AUD |
| 200-Day Moving Average | 0.11 AUD |
RNO.AX Share Statistics
| Avg. Volume (3 month) | 97.76K AUD |
| Avg. Daily Volume (10-Days) | 61.18K AUD |
| Shares Outstanding | 285.72M |
| Float | 80.03M |
| Short Ratio | N/A |
| % Held by Insiders | 70.30% |
| % Held by Institutions | 0.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -71.054% |
| Operating Margin (ttm) | -78.00000000000000000000000000000000% |
| Gross Margin | 71.91% |
| EBITDA Margin | -70.53% |
Management Effectiveness
| Return on Assets (ttm) | -58.19% |
| Return on Equity (ttm) | -388.12% |
Income Statement
| Revenue (ttm) | 9.41M AUD |
| Revenue Per Share (ttm) | 0.03 AUD |
| Quarterly Revenue Growth (yoy) | -5.00000000000000000000000000000000% |
| Gross Profit (ttm) | 6.71M AUD |
| EBITDA | -6636798 AUD |
| Net Income Avi to Common (ttm) | -6685503 AUD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.63M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 4.74M AUD |
| Total Debt/Equity (mrq) | 2261.76 AUD |
| Current Ratio (mrq) | 0.761 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6306406 AUD |
| Levered Free Cash Flow (ttm) | -3946494 AUD |
Profile of Rhinomed Limited
| Country | Australia |
| State | VIC |
| City | Cremorne |
| Address | 132 Gwynne Street |
| ZIP | 3121 |
| Phone | 61 3 8416 0900 |
| Website | https://www.rhinomed.global |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.
Q&A For Rhinomed Limited Stock
What is a current RNO.AX stock price?
Rhinomed Limited RNO.AX stock price today per share is 0.04 AUD.
How to purchase Rhinomed Limited stock?
You can buy RNO.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rhinomed Limited?
The stock symbol or ticker of Rhinomed Limited is RNO.AX.
Which industry does the Rhinomed Limited company belong to?
The Rhinomed Limited industry is Medical Devices.
How many shares does Rhinomed Limited have in circulation?
The max supply of Rhinomed Limited shares is 286.78M.
What is Rhinomed Limited Price to Earnings Ratio (PE Ratio)?
Rhinomed Limited PE Ratio is 0.00000000 now.
What was Rhinomed Limited earnings per share over the trailing 12 months (TTM)?
Rhinomed Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Rhinomed Limited company belong to?
The Rhinomed Limited sector is Healthcare.